Novartis
The Senior Scientist will work in Novartis' R&D unit in Mengeš, focusing on pre‑formulation and formulation development of large biotherapeutic molecules such as monoclonal and multispecific antibodies. The role involves designing and executing formulation screening studies, performing biophysical characterisation, and shaping formulation strategies to guide candidates from research into early‑phase development.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
67% below the average for this role
Associate Scientist - Formulation Development
MSD
Scientist- Protein Formulation Development
AbbVie
Principal Scientist
GSK plc
Senior Associate Scientist, Formulation Development (Peptide and Antibody)
Regeneron Pharmaceuticals
Lead or Principal Scientist
Zealand Pharma
Sr. Associate/Consultant - Biopharma Formulations
Elanco